11th Nov 2020 10:48
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 10 November 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD |
|
| ||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
3,168,008 | 2.46% | 687,185 | 0.53% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
366,484 | 0.28% | 739,005 | 0.57% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
3,534,492 | 2.74% | 1,426,190 | 1.11% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 2 | 200.4100 USD |
| Purchase | 3 | 199.9100 USD |
| Purchase | 8 | 200.0500 USD |
| Purchase | 19 | 199.8905 USD |
| Purchase | 24 | 200.3935 USD |
| Purchase | 36 | 200.3983 USD |
| Purchase | 40 | 200.5700 USD |
| Purchase | 44 | 198.3661 USD |
| Purchase | 67 | 201.3437 USD |
| Purchase | 100 | 202.2500 USD |
| Purchase | 100 | 200.4400 USD |
| Purchase | 100 | 200.3700 USD |
| Purchase | 100 | 202.2200 USD |
| Purchase | 132 | 200.2995 USD |
| Purchase | 200 | 200.5850 USD |
| Purchase | 201 | 201.4006 USD |
| Purchase | 209 | 196.3700 USD |
| Purchase | 215 | 198.7131 USD |
| Purchase | 235 | 200.4597 USD |
| Purchase | 251 | 198.7188 USD |
| Purchase | 254 | 200.5594 USD |
| Purchase | 300 | 200.4974 USD |
| Purchase | 493 | 200.3673 USD |
| Purchase | 520 | 200.2108 USD |
| Purchase | 532 | 200.4962 USD |
| Purchase | 769 | 199.8893 USD |
| Purchase | 900 | 202.1400 USD |
| Purchase | 1,158 | 200.4758 USD |
| Purchase | 1,751 | 199.5451 USD |
| Purchase | 1,755 | 199.5507 USD |
| Purchase | 1,830 | 200.2880 USD |
| Purchase | 2,336 | 200.4854 USD |
| Purchase | 2,946 | 202.0100 USD |
| Purchase | 3,214 | 198.8790 USD |
| Purchase | 3,493 | 200.4009 USD |
| Purchase | 4,594 | 199.2406 USD |
| Purchase | 4,909 | 201.4965 USD |
| Purchase | 5,154 | 199.5457 USD |
| Purchase | 5,903 | 200.4094 USD |
| Purchase | 23,523 | 200.5974 USD |
| Purchase | 29,892 | 200.3379 USD |
| Purchase | 49,237 | 199.7642 USD |
| Sale | 1 | 200.1700 USD |
| Sale | 2 | 199.0650 USD |
| Sale | 3 | 199.9100 USD |
| Sale | 4 | 199.7850 USD |
| Sale | 5 | 200.4000 USD |
| Sale | 39 | 198.1053 USD |
| Sale | 40 | 200.5700 USD |
| Sale | 43 | 198.3300 USD |
| Sale | 130 | 201.9826 USD |
| Sale | 200 | 197.7300 USD |
| Sale | 300 | 202.1600 USD |
| Sale | 571 | 200.0284 USD |
| Sale | 900 | 201.7994 USD |
| Sale | 900 | 201.5166 USD |
| Sale | 1,058 | 200.3307 USD |
| Sale | 1,100 | 199.1781 USD |
| Sale | 1,440 | 199.5234 USD |
| Sale | 1,731 | 199.4089 USD |
| Sale | 3,265 | 198.9371 USD |
| Sale | 3,851 | 202.0100 USD |
| Sale | 5,043 | 201.3619 USD |
| Sale | 10,000 | 200.4358 USD |
| Sale | 27,849 | 200.3598 USD |
| Sale | 89,902 | 199.9867 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 11 Nov 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201111005388/en/
Copyright Business Wire 2020
Related Shares:
Barclays